Damora Therapeutics (DMRA) Times Interest Earned (2019 - 2026)
Damora Therapeutics (DMRA) posted Times Interest Earned of -$2.7 for Q1 2026, up 99.99% on a QoQ basis from -$40339.2 in Q4 2025, and up 90.87% year-over-year from -$1.41 in Q1 2025.
Damora Therapeutics (DMRA) Times Interest Earned (2019 - 2026) Analysis & Trends
Damora Therapeutics' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$2.7 for Q1 2026.
- Quarterly Times Interest Earned rose 90.87% year-over-year to -$2.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.93 (up 90.36% YoY) and the FY2025 annual result came in at -$2.8, down 744.29% from the prior year.
- Times Interest Earned was -$2.7 for Q1 2026 at Damora Therapeutics, up from -$40339.2 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$2.7 in Q1 2026 and bottomed at -$40339.2 in Q4 2025.
- A 5-year average of -$2443.7 and a median of -$70.93 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned soared 97.6% — and 2025, when it slumped 18643.93%.
- Damora Therapeutics' Times Interest Earned stood at -$87.26 in 2022, then surged by 55.29% to -$39.01 in 2023, then tumbled by 451.66% to -$215.21 in 2024, then slumped by 18643.93% to -$40339.2 in 2025, then soared by 99.99% to -$2.7 in 2026.
- Business Quant data shows DMRA's Times Interest Earned at -$2.7 in Q1 2026, -$40339.2 in Q4 2025, and -$157.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | -2.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.70 |
| Dec 31, 2025 | -40,339.20 |
| Sep 30, 2025 | -157.80 |
| Jun 30, 2025 | -38.44 |
| Mar 31, 2025 | -29.53 |
| Dec 31, 2024 | -215.21 |
| Sep 30, 2024 | -76.80 |
| Jun 30, 2024 | -116.19 |
| Mar 31, 2024 | -62.40 |
| Dec 31, 2023 | -39.01 |
| Sep 30, 2023 | -70.93 |
| Jun 30, 2023 | -3.43 |
| Mar 31, 2023 | -9.43 |
| Dec 31, 2022 | -87.26 |
| Sep 30, 2022 | -101.66 |
| Jun 30, 2022 | -142.68 |
| Mar 31, 2022 | -49.78 |
| Dec 31, 2021 | -122.44 |
| Sep 30, 2021 | -6.28 |
| Jun 30, 2021 | -3.07 |